The STOP TRANQ Act requires the State Department to identify and track countries that are significant sources of xylazine, a powerful tranquilizer increasingly mixed into illegal drugs like fentanyl. The bill amends the International Narcotics Control Strategy Report, an annual assessment submitted to Congress, to include xylazine alongside other illicit drugs already being monitored for international trafficking. This change affects U.S. foreign policy and drug enforcement efforts by expanding surveillance of the global supply chains that bring dangerous drugs into the United States. The legislation does not authorize new funding but integrates xylazine monitoring into an existing reporting requirement. The bill addresses growing concerns about xylazine contamination in the illicit drug supply, which has become a significant public health threat contributing to overdose deaths.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.